Skip to main content
. 2021 Jan 29;8(2):156–163. doi: 10.4103/apjon.apjon_56_20

Table 4.

Comparison of the evolution of symptoms between the two groups

Variables Mean (SD) P*

Intervention group Control group
Fatigue
 Baseline 32.6 (32.3) 26.2 (23.2) 0.391
 Postintervention 28.3 (25.1) 29.0 (25.9)
Difference −4.3 2.8
Nausea and vomiting
 Baseline 11.9 (25.2) 14.1 (24.1) 0.882
 Postintervention 11.8 (18.4) 9.7 (18.0)
Difference −0.1 −4.4
Pain
 Baseline 24.8 (34.5) 19.5 (31.1) 0.220
 Postintervention 16.1 (21.7) 20.4 (32.4)
Difference −8.7 0.9
Dyspnea
 Baseline 2.7 (9.2) 12.1 (22.3) 0.007
 Postintervention 11.8 (26.6) 6.5 (15.6)
Difference 9.1 −5.6
Insomnia
 Baseline 34.7 (37.2) 27.0 (37.2) 0.053
 Postintervention 21.5 (33.9) 32.4 (38.6)
Difference −13.2 5.4
Loss of appetite
 Baseline 34.7 (41.9) 17.8 (32.0) 0.002
 Postintervention 14.0 (28.3) 20.4 (34.1)
Difference −20.7 2.6
Constipation
 Baseline 23.1 (36.1) 12.1 (27.0) 0.344
 Postintervention 23.6 (35.7) 17.6 (33.3)
Difference 0.5 5.5
Diarrhea
 Baseline 12.9 (24.4) 12.6 (24.8) 0.658
 Postintervention 16.1 (30.9) 17.6 (29.3)
Difference 3.2 5.0

*Group × time interaction effect from a linear mixed-effects model. SD: Standard deviation